Christine Rootwelt-Norberg

MD, PhD-fellow, Dept of Cardiology, Oslo University Hospital & ProCardio Center for Innovation

[HeartRhythm @hrs_journal]

Timing of ICD implantation in patients with cardiac laminopathies - external validation of the LMNA-risk VTA calculator. @NorbergRootwelt @KristinaHaugaa @oyvlie OPEN ACCESS!
https://t.co/v3e50D0Mo5

[Kristina Haugaa @KristinaHaugaa]

Flecainide in patients with arrhythmic mitral valve syndrome reduces PVCs and nsVTs https://t.co/SF3q7Ofv40

[European Society of Cardiology Journals @ESC_Journals]

Disease progression rate is a strong predictor of ventricular arrhythmias in pts w/ cardiac laminopathies. Discover more 👉
https://t.co/wF4PKEm4Yn

@EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMd @AndyZhangMD @marcovitoloMD @KristinaHaugaa @norbergRootwelt #genetics

[Kristina Haugaa @KristinaHaugaa]

Flecainide may help symptoms in AMVP. More to come…@ProCardio1 @eivindaabel @NorbergRootwelt @IsottaCastrini @escardio @EHRAPresident @hrs_journal
Flecainide in patients with arrhythmic mitral valve syndrome - a case series. https://t.co/7MKxVxgW2a

[Christine Rootwelt-Norberg @NorbergRootwelt]

So happy and proud for how this PhD-defence turned out😁🎓 Forever grateful for supervisors @KristinaHaugaa and @oyvlie, all of @ProCardio1, @ThorEdvardsen and the rest of the Department of Cardiology Rikshospitalet and @UniOslo_MED

[Øyvind H Lie @oyvlie]

Science superstar @NorbergRootwelt absolutely nailing her PhD-defence! Proud supervisor🙋‍♂️ Congrats to all @ProCardio1 @KristinaHaugaa @UniOslo_MED

[Christine Rootwelt-Norberg @NorbergRootwelt]

In patients with cardiac laminopathies, disease progression rate by ECG and echo is an important predictor of future life-threatening arrhythmias.
Happy to get this out! Thanks @KristinaHaugaa and @oyvlie for excellent supervision and guidance, as always. @ProCardio1

[Kristina Haugaa @KristinaHaugaa]

Well done @NorbergRootwelt @eivindaabel and all @ProCardio1 ! #EHRA_ESC #Europace Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study https://t.co/ZVATwU6iAv

[Kristina Haugaa @KristinaHaugaa]

Our paper was published in EHJ @ESC_Journals simultaneously with our presentation. @escardio @ProCardio1 Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy https://t.co/6jslrQilLF

[Kristina Haugaa @KristinaHaugaa]

Important work and one step towards understanding exercise induced ARVC @ProCardio1 @NorbergRootwelt @escardio @ESC_Journals

[Christine Rootwelt-Norberg @NorbergRootwelt]

Honored and happy for this great achievement - EuroEcho Young Investigator Award 2021. Thank you @escardio for an excellent congress. And a big thanks to @KristinaHaugaa and @oyvlie for their great guidance and support every step of the way.#euroecho @ProCardio1

[Thor Edvardsen @ThorEdvardsen]

Congratulations as the winner of the #euroecho YIA @NorbergRootwelt

[Christine Rootwelt-Norberg @NorbergRootwelt]

Females with arrhythmogenic cardiomyopathy seem to have equally high risk of life-threatening events as males. An important finding in regards to risk stratification!

[ProCardioSFI @ProCardio1]

New article on sex differences in Arrhythmogenic Cardiomyopathy! Higher arrhythmic risk in males was confounded by exercise habits. No sex differences in disease progression after exercise restriction. Open access: https://t.co/ZGtX1YXQEj

[ProCardioSFI @ProCardio1]

New article on sex differences in Arrhythmogenic Cardiomyopathy! Higher arrhythmic risk in males was confounded by exercise habits. No sex differences in disease progression after exercise restriction. Open access: https://t.co/ZGtX1YXQEj